Cargando…

Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation

AIMS: A key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca(2+)-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can i...

Descripción completa

Detalles Bibliográficos
Autores principales: Funk, Florian, Kronenbitter, Annette, Hackert, Katarzyna, Oebbeke, Matthias, Klebe, Gerhard, Barth, Mareike, Koch, Daniel, Schmitt, Joachim P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318394/
https://www.ncbi.nlm.nih.gov/pubmed/36869774
http://dx.doi.org/10.1093/cvr/cvad037
_version_ 1785068027883028480
author Funk, Florian
Kronenbitter, Annette
Hackert, Katarzyna
Oebbeke, Matthias
Klebe, Gerhard
Barth, Mareike
Koch, Daniel
Schmitt, Joachim P
author_facet Funk, Florian
Kronenbitter, Annette
Hackert, Katarzyna
Oebbeke, Matthias
Klebe, Gerhard
Barth, Mareike
Koch, Daniel
Schmitt, Joachim P
author_sort Funk, Florian
collection PubMed
description AIMS: A key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca(2+)-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can inhibit SERCA2a by direct interaction, the functional role of pentamers is still unclear. This study investigates the functional consequences of PLN pentamerization. METHODS AND RESULTS: We generated transgenic mouse models expressing either a PLN mutant that cannot form pentamers (TgAFA-PLN) or wild-type PLN (TgPLN) in a PLN-deficient background. TgAFA-PLN hearts demonstrated three-fold stronger phosphorylation of monomeric PLN, accelerated Ca(2+) cycling of cardiomyocytes, and enhanced contraction and relaxation of sarcomeres and whole hearts in vivo. All of these effects were observed under baseline conditions and abrogated upon inhibition of protein kinase A (PKA). Mechanistically, far western kinase assays revealed that PLN pentamers are phosphorylated by PKA directly and independent of any subunit exchange for free monomers. In vitro phosphorylation of synthetic PLN demonstrated that pentamers even provide a preferred PKA substrate and compete with monomers for the kinase, thereby reducing monomer phosphorylation and maximizing SERCA2a inhibition. However, β-adrenergic stimulation induced strong PLN monomer phosphorylation in TgPLN hearts and sharp acceleration of cardiomyocyte Ca(2+) cycling and haemodynamic values that now were indistinguishable from TgAFA-PLN and PLN-KO hearts. The pathophysiological relevance of PLN pentamerization was evaluated using transverse aortic constriction (TAC) to induce left ventricular pressure overload. Compared to TgPLN, TgAFA-PLN mice demonstrated reduced survival after TAC, impaired cardiac haemodynamics, failure to respond to adrenergic stimulation, higher heart weight, and increased myocardial fibrosis. CONCLUSIONS: The findings show that PLN pentamerization greatly impacts on SERCA2a activity as it mediates the full range of PLN effects from maximum inhibition to full release of SERCA2a function. This regulation is important for myocardial adaptation to sustained pressure overload.
format Online
Article
Text
id pubmed-10318394
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103183942023-07-05 Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation Funk, Florian Kronenbitter, Annette Hackert, Katarzyna Oebbeke, Matthias Klebe, Gerhard Barth, Mareike Koch, Daniel Schmitt, Joachim P Cardiovasc Res Original Article AIMS: A key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca(2+)-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can inhibit SERCA2a by direct interaction, the functional role of pentamers is still unclear. This study investigates the functional consequences of PLN pentamerization. METHODS AND RESULTS: We generated transgenic mouse models expressing either a PLN mutant that cannot form pentamers (TgAFA-PLN) or wild-type PLN (TgPLN) in a PLN-deficient background. TgAFA-PLN hearts demonstrated three-fold stronger phosphorylation of monomeric PLN, accelerated Ca(2+) cycling of cardiomyocytes, and enhanced contraction and relaxation of sarcomeres and whole hearts in vivo. All of these effects were observed under baseline conditions and abrogated upon inhibition of protein kinase A (PKA). Mechanistically, far western kinase assays revealed that PLN pentamers are phosphorylated by PKA directly and independent of any subunit exchange for free monomers. In vitro phosphorylation of synthetic PLN demonstrated that pentamers even provide a preferred PKA substrate and compete with monomers for the kinase, thereby reducing monomer phosphorylation and maximizing SERCA2a inhibition. However, β-adrenergic stimulation induced strong PLN monomer phosphorylation in TgPLN hearts and sharp acceleration of cardiomyocyte Ca(2+) cycling and haemodynamic values that now were indistinguishable from TgAFA-PLN and PLN-KO hearts. The pathophysiological relevance of PLN pentamerization was evaluated using transverse aortic constriction (TAC) to induce left ventricular pressure overload. Compared to TgPLN, TgAFA-PLN mice demonstrated reduced survival after TAC, impaired cardiac haemodynamics, failure to respond to adrenergic stimulation, higher heart weight, and increased myocardial fibrosis. CONCLUSIONS: The findings show that PLN pentamerization greatly impacts on SERCA2a activity as it mediates the full range of PLN effects from maximum inhibition to full release of SERCA2a function. This regulation is important for myocardial adaptation to sustained pressure overload. Oxford University Press 2023-03-03 /pmc/articles/PMC10318394/ /pubmed/36869774 http://dx.doi.org/10.1093/cvr/cvad037 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Funk, Florian
Kronenbitter, Annette
Hackert, Katarzyna
Oebbeke, Matthias
Klebe, Gerhard
Barth, Mareike
Koch, Daniel
Schmitt, Joachim P
Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
title Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
title_full Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
title_fullStr Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
title_full_unstemmed Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
title_short Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
title_sort phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318394/
https://www.ncbi.nlm.nih.gov/pubmed/36869774
http://dx.doi.org/10.1093/cvr/cvad037
work_keys_str_mv AT funkflorian phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation
AT kronenbitterannette phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation
AT hackertkatarzyna phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation
AT oebbekematthias phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation
AT klebegerhard phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation
AT barthmareike phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation
AT kochdaniel phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation
AT schmittjoachimp phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation